HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis ...

Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced ...

Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is ...

USA 7 Department of Pathology, Children's Hospital Colorado, Aurora, Colorado, USA Objective Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition of the oesophagus with limited ...

From acid reflux to immune reactions, esophagitis has many causes—learn about its symptoms, types, and the latest treatments ...

A pilot study shows that advanced practice providers can be trained to perform safe and successful transnasal endoscopy, ...

Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR ...

To assess the impact of food allergies on the progression of atopic dermatitis to other atopic disorders, researchers analyzed electronic health records from 10,688 children (57.5% boys) who had ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil ...